INFUSYSTEM HOLDINGS, INC Accounts Receivable, Allowance for Credit Loss
INFUSYSTEM HOLDINGS, INC (INFU) had Accounts Receivable, Allowance for Credit Loss of $3.14 million as of 2012-12-31, per its 10-K filed 2013-03-28.
Discontinued › Balance Sheet › Assets
us-gaap:AllowanceForDoubtfulAccountsReceivable · last filed 2013-03-28
- 2012-12-31: Accounts Receivable, Allowance for Credit Loss $3.14M.
- 2011-12-31: Accounts Receivable, Allowance for Credit Loss $1.77M.
- 2010-12-31: Accounts Receivable, Allowance for Credit Loss $1.80M.
| Period end | Accounts Receivable, Allowance for Credit Loss |
|---|---|
| 2012-12-31 | $3.14M 10-K · filed 2013-03-28 |
| 2011-12-31 | $1.77M 10-K · filed 2013-03-28 |
| 2010-12-31 | $1.80M 10-K · filed 2013-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 |